
MS Pilot Study Data to Be Presented at the International Neuropsychological Society Mid-Year Meeting in London (July 6-8)
Helius Medical Technologies, Inc. (TSX:HSM)(OTCQB:HSDT) ("Helius" or the "Company") is pleased to announce that the results from the Multiple Sclerosis (MS) Pilot Study, investigating PoNS™ Therapy, will be presented in London on July …